Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The project was not funded.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Massachusetts General Hospital | OTHER |
| Mclean Hospital | OTHER |
| Massachusetts Institute of Technology | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a multi-site study of adolescents 12-21 years-of-age to evaluate the long and shorter-term effect of adolescent alcohol use on the developing brain.
The overall specific aims of this study are to: 1) assess the short and long-term consequences of alcohol exposure on brain, cognitive, and emotional/regulatory development during preadolescence and adolescence; 2) determine the effects of timing, dose, and duration of alcohol on brain and cognitive development; 3) assess recovery of neural and behavioral function to determine if the plasticity of the adolescent brain makes it more or less vulnerable to alcohol's acute and chronic effects; 4) understand how other key covariates (e.g., existing or emerging psychopathology, family history of alcoholism, demographics, pubertal development) factor into alcohol's effects on the brain; and 5) identify early neural, cognitive, and affective markers that may predict alcohol abuse and dependence during adolescence and/or adulthood.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Alcohol-naive adolescents | A general population longitudinal cohort of alcohol-naïve (or h/o minimal recent-onset drinking) adolescents in three specific age-groups: early (12-14 y/o), middle (15-17 y/o), and late (18-21 y/o). | ||
| Treatment sample | A sample of adolescents who have a >1 year history of heavy drinking but have agreed to stop drinking as part of their treatment plan | ||
| High risk sample | High-risk adolescents who have a family history of alcohol-use disorder and other risk factors (symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD), Conduct Disorder, or Mood Disorder) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Male and female adolescents 12-21 years-of-age presenting for care at one of the participating medical clinics
Not provided
| Name | Affiliation | Role |
|---|---|---|
| John R Knight, MD | Boston Children's Hospital | Principal Investigator |
| Gordon J Harris, PhD | Massachusetts General Hospital | Principal Investigator |
| Simon Warfield, PhD | Boston Children's Hospital | Principal Investigator |
| Avram Holmes, PhD | Harvard University | Principal Investigator |
| Scott Lukas, PhD | Mclean Hospital | Principal Investigator |
| Marisa Silveri, PhD | Mclean Hospital | Principal Investigator |
| Marlene Oscar Berman, PhD | Boston University | Principal Investigator |
| John Gabrieli, PhD | Massachusetts Institute of Technology | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| McLean Hospital | Belmont | Massachusetts | 02478 | United States | ||
| Massachusetts General Hospital |
Not provided
| Label | URL |
|---|---|
| Center for Adolescent Substance Abuse Research at Children's Hospital Boston | View source |
Not provided
Not provided
| ID | Term |
|---|---|
| D000437 | Alcoholism |
| ID | Term |
|---|---|
| D019973 | Alcohol-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Saliva DNA samples for future analyses.
| Boston |
| Massachusetts |
| 02114 |
| United States |
| Boston University School of Medicine | Boston | Massachusetts | 02118 | United States |
| Massachusetts Institute of Technology | Cambridge | Massachusetts | 02139 | United States |